Refocus Group, Inc. (RFCS)
Refocus Group, Inc. operates in the Medical - Devices industry of the Healthcare sector, headquartered in Dallas, TX, US. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $25. Its beta of -0.58 implies it has historically moved less than the broad market.
Refocus Group, Inc. is a medical technology firm dedicated to the research and creation of therapies for various human vision conditions, particularly presbyopia. A key offering is the VisAbility Micro-Insert System, an experimental medical device currently undergoing clinical evaluations for its application in treating presbyopia affecting both eyes. The organization caters to the needs of both patients and ophthalmic professionals. Founded in 1994, this company operates from its base in Dallas, Texas.
Refocus Group, Inc. is most often compared with the following Healthcare names: